The Clippers seem to be done with all their moves this summer and will probably just sign minimum level contracts from here on out, writes Eric Pincus of HoopsWorld (via Twitter). But Pincus also tweeted an update on the Clippers' salary info after the Darren Collison signing that used part of their available MLE earlier tonight.
The deal means Matt Barnes will get less as part of his announced re-signing with the Clippers yesterday. It was reported he'd worked out a three-year deal worth between $11-$12MM, but after Pincus' math that's likely to drop as they split the MLE with Barnes dropping to $10MM over three years.
Here's some more around the league, including teams pursuing free agent Wayne Ellington and the Cavs' future after signing Jarrett Jack.
- League sources tell RealGM's Shams Charania that the Kings are eyeing free agent Sam Young of the Pacers.
- Sam Amico of Fox Sports Ohio says free agent guard Wayne Ellington is drawing interest from the Bulls, Bucks and Pistons (Twitter).
- About the Pistons, USA Today's Jeff Zillgitt says (via Twitter) that even though they landed free agent Josh Smith, they still want a point guard and shooting wing, the latter role one Ellington could fulfill.
- Keith Langlois of Pistons.com says (via Twitter) that there are 34 players making over $13.5MM next season. He goes on to say that number helps put "youknowwhat" into perspective. We're guessing it's the four-year $54MM (or $56MM, with performance incentives) Josh Smith just agreed to signed for with the Pistons.
- A source has told 1500ESPN.com's Darren Wolfson the Timberwolves are maintaining a regular dialogue with unrestricted free agent Alan Anderson's camp (Twitter).
- Jason Lloyd of the Akron Beacon Journal takes a look at how the Cavs roster is beginning to take shape in the wake of their agreement with Jarrett Jack.
- Lloyd adds (via Twitter) that the Jack signing probably ends their flirtation with Ellington, whom they didn't tender a qualifying offer because they wanted an upgrade of the kind Jack gives them.